Hydrogen-rich water improves neurological functional recovery in experimental autoimmune encephalomyelitis mice.
Ming Zhao, Ming-Dong Liu, Ying-Yan Pu, Dan Wang, Yu Xie, Gai-Ci Xue, Yong Jiang, Qian-Qian Yang, Xue-Jun Sun, Li Cao · Journal of neuroimmunology · 2016
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In an animal model, 0.89mM HRW also reduced disease severity, CNS infiltration, and demyelination when administered after the onset of disease. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how hydrogen-rich water was evaluated in this publication and summarizes the source-grounded findings below. 0.89mM HRW also reduced disease severity, CNS infiltration, and demyelination when administered after the onset of disease.
What the Researchers Studied
The study used a preclinical animal experiment.
What Effects Did Molecular Hydrogen Have?
Molecular hydrogen (H₂) has been reported to exhibit anti-oxidant, anti-apoptotic, anti-inflammatory, anti-allergy, and anti-cancer effects. 0.89mM HRW also reduced disease severity, CNS infiltration, and demyelination when administered after the onset of disease. The authors concluded that because HRW is non-toxic, inexpensive, easily administered, and can readily cross the blood-brain barrier, the experiments suggest that HRW may have great potential in the treatment of MS.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The study used a preclinical animal experiment. The hydrogen delivery method was hydrogen-rich water.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.